Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Janux Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +15 vs. Q2 2021
- Shares held
- 26.5M
- +1.76M (+7.1%) vs. Q2 2021
- Total value
- $571.2M
- −$43.3M (−7.0%) vs. Q2 2021
- New holders
- 24
- 9 more added
- Sold out
- 9
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,670,644 | $187.5M | 2.60% | 00.0% | Unchanged |
| FMR LLC | 3,615,431 | $78.2M | 0.01% | +1,771,867+96.1% | Added |
| OrbiMed Advisors LLC | 3,466,386 | $75.0M | 0.83% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,416,404 | $51.4M | 0.02% | −251,803−9.4% | Reduced |
| Citadel Advisors LLC | 1,859,246 | $39.6M | 0.04% | −27,466−1.5% | Reduced |
| EcoR1 Capital, LLC | 1,411,975 | $30.5M | 1.08% | 00.0% | Unchanged |
| BVF Inc | 1,017,314 | $22.0M | 0.86% | −159,367−13.5% | Reduced |
| BlackRock Inc. | 801,778 | $17.3M | 0.00% | +691,831+629.2% | Added |
| Vanguard Group Inc | 530,242 | $11.5M | 0.00% | +501,266+1,729.9% | Added |
| 5AM Venture Management, LLC | 446,266 | $9.65M | 1.96% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 411,871 | $8.91M | 1.48% | −196,078−32.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $8.65M | 0.02% | −50,000−11.1% | Reduced |
| Woodline Partners LP | 300,031 | $6.49M | 0.11% | −34,229−10.2% | Reduced |
| Logos Global Management LP | 247,122 | $4.81M | 0.35% | −300,000−54.8% | Reduced |
| Geode Capital Management, LLC | 211,880 | $4.58M | 0.00% | +189,863+862.3% | Added |
| State Street Corp | 174,644 | $3.78M | 0.00% | +174,644 | New |
| Northern Trust Corp | 116,961 | $2.53M | 0.00% | +116,961 | New |
| SG Americas Securities, LLC | 65,414 | $1.42M | 0.01% | +65,414 | New |
| Parametric Portfolio Associates LLC | 59,366 | $1.28M | 0.00% | +59,366 | New |
| D. E. Shaw & Co., Inc. | 46,156 | $998.0K | 0.00% | +46,156 | New |
| Janney Montgomery Scott LLC | 40,860 | $884.0K | 0.00% | +40,860 | New |
| Charles Schwab Investment Management Inc | 32,576 | $705.0K | 0.00% | +32,576 | New |
| Bank of New York Mellon Corp | 31,473 | $681.0K | 0.00% | +31,473 | New |
| Parkwood LLC | 20,777 | $449.0K | 0.08% | +20,777 | New |
| Nuveen Asset Management, LLC | 19,457 | $421.0K | 0.00% | +19,457 | New |
| Rhumbline Advisers | 11,110 | $240.0K | 0.00% | +11,110 | New |
| Chicago Partners Investment Group LLC | 9,458 | $235.0K | 0.02% | +9,458 | New |
| Deutsche Bank AG | 8,185 | $178.0K | 0.00% | +8,185 | New |
| American International Group, Inc. | 7,242 | $157.0K | 0.00% | +7,242 | New |
| California State Teachers Retirement System | 7,149 | $155.0K | 0.00% | +7,149 | New |
| Morgan Stanley | 6,702 | $145.0K | 0.00% | +6,602+6,602.0% | Added |
| JPMorgan Chase & Co | 6,474 | $140.0K | 0.00% | +5,828+902.2% | Added |
| MetLife Investment Management | 5,302 | $114.7K | 0.00% | +5,302 | New |
| Metropolitan Life Insurance Co | 4,011 | $86.8K | 0.00% | +4,011 | New |
| UBS Group AG | 3,500 | $76.0K | 0.00% | +3,147+891.5% | Added |
| STRS Ohio | 3,000 | $64.0K | 0.00% | +3,000 | New |
| Bank of America Corp | 2,943 | $63.0K | 0.00% | +895+43.7% | Added |
| Royal Bank of Canada | 2,837 | $61.0K | 0.00% | +1,537+118.2% | Added |
| New York State Common Retirement Fund | 2,300 | $50.0K | 0.00% | +2,300 | New |
| Citigroup Inc | 1,755 | $38.0K | 0.00% | −84,940−98.0% | Reduced |
| Legal & General Group Plc | 1,239 | $27.0K | 0.00% | +1,239 | New |
| Ameritas Investment Partners, Inc. | 1,014 | $22.0K | 0.00% | +1,014 | New |
| Tower Research Capital LLC (TRC) | 522 | $11.0K | 0.00% | +522 | New |
| Evolution Wealth Advisors, LLC | 124 | $3.00K | 0.00% | +124 | New |
| Wells Fargo & Company | 74 | $2.00K | 0.00% | +74 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −75,257−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −69,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −32,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,567−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,309−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −9,165−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −7−100.0% | Sold out |